Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
desmopressin vasopressin v1a receptor small molecule Successful target TTD , drugbank , DGIDB von Willebrand Disease
Type 1[MeSHID:D056725]
Disease Management[MeSHID:D019468]
Hemostatic function[MeSHID:D006487]
Urination[MeSHID:D014554]
Maintenance[MeSHID:D008283]
Pituitary Gland[MeSHID:D010902]
Operative Surgical Procedures[MeSHID:D013514]
Polyuria[MeSHID:D011141]
Nocturia[MeSHID:D053158]
Hemophilia A[MeSHID:D006467]
Polydipsia[MeSHID:D059606]
Pituitary Diseases[MeSHID:D010900]
Craniocerebral Trauma[MeSHID:D006259]
Central Diabetes Insipidus[MeSHID:D020790]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]		 5.3 approved agonist
desmopressin vasopressin v1a receptor small molecule Successful target TTD , drugbank , DGIDB von Willebrand Disease
Type 1[MeSHID:D056725]
Disease Management[MeSHID:D019468]
Hemostatic function[MeSHID:D006487]
Urination[MeSHID:D014554]
Maintenance[MeSHID:D008283]
Pituitary Gland[MeSHID:D010902]
Operative Surgical Procedures[MeSHID:D013514]
Polyuria[MeSHID:D011141]
Nocturia[MeSHID:D053158]
Hemophilia A[MeSHID:D006467]
Polydipsia[MeSHID:D059606]
Pituitary Diseases[MeSHID:D010900]
Craniocerebral Trauma[MeSHID:D006259]
Central Diabetes Insipidus[MeSHID:D020790]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]		 5.3 approved unknown
desmopressin vasopressin v1b receptor small molecule Successful target TTD , drugbank , DGIDB von Willebrand Disease
Type 1[MeSHID:D056725]
Disease Management[MeSHID:D019468]
Hemostatic function[MeSHID:D006487]
Urination[MeSHID:D014554]
Maintenance[MeSHID:D008283]
Pituitary Gland[MeSHID:D010902]
Operative Surgical Procedures[MeSHID:D013514]
Polyuria[MeSHID:D011141]
Nocturia[MeSHID:D053158]
Hemophilia A[MeSHID:D006467]
Polydipsia[MeSHID:D059606]
Pituitary Diseases[MeSHID:D010900]
Craniocerebral Trauma[MeSHID:D006259]
Central Diabetes Insipidus[MeSHID:D020790]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]		 6.19 approved agonist
desmopressin vasopressin v1b receptor small molecule Successful target TTD , drugbank , DGIDB von Willebrand Disease
Type 1[MeSHID:D056725]
Disease Management[MeSHID:D019468]
Hemostatic function[MeSHID:D006487]
Urination[MeSHID:D014554]
Maintenance[MeSHID:D008283]
Pituitary Gland[MeSHID:D010902]
Operative Surgical Procedures[MeSHID:D013514]
Polyuria[MeSHID:D011141]
Nocturia[MeSHID:D053158]
Hemophilia A[MeSHID:D006467]
Polydipsia[MeSHID:D059606]
Pituitary Diseases[MeSHID:D010900]
Craniocerebral Trauma[MeSHID:D006259]
Central Diabetes Insipidus[MeSHID:D020790]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]		 6.19 approved unknown
desmopressin vasopressin v2 receptor small molecule Successful target TTD , drugbank , DGIDB von Willebrand Disease
Type 1[MeSHID:D056725]
Disease Management[MeSHID:D019468]
Hemostatic function[MeSHID:D006487]
Urination[MeSHID:D014554]
Maintenance[MeSHID:D008283]
Pituitary Gland[MeSHID:D010902]
Operative Surgical Procedures[MeSHID:D013514]
Polyuria[MeSHID:D011141]
Nocturia[MeSHID:D053158]
Hemophilia A[MeSHID:D006467]
Polydipsia[MeSHID:D059606]
Pituitary Diseases[MeSHID:D010900]
Craniocerebral Trauma[MeSHID:D006259]
Central Diabetes Insipidus[MeSHID:D020790]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]		 3.82 approved agonist
desmopressin oxytocin receptor NA Successful target TTD , DGIDB von Willebrand Disease
Type 1[MeSHID:D056725]
Disease Management[MeSHID:D019468]
Hemostatic function[MeSHID:D006487]
Urination[MeSHID:D014554]
Maintenance[MeSHID:D008283]
Pituitary Gland[MeSHID:D010902]
Operative Surgical Procedures[MeSHID:D013514]
Polyuria[MeSHID:D011141]
Nocturia[MeSHID:D053158]
Hemophilia A[MeSHID:D006467]
Polydipsia[MeSHID:D059606]
Pituitary Diseases[MeSHID:D010900]
Craniocerebral Trauma[MeSHID:D006259]
Central Diabetes Insipidus[MeSHID:D020790]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]		 3.35 approved agonist
desmopressin oxytocin receptor NA Successful target TTD , DGIDB von Willebrand Disease
Type 1[MeSHID:D056725]
Disease Management[MeSHID:D019468]
Hemostatic function[MeSHID:D006487]
Urination[MeSHID:D014554]
Maintenance[MeSHID:D008283]
Pituitary Gland[MeSHID:D010902]
Operative Surgical Procedures[MeSHID:D013514]
Polyuria[MeSHID:D011141]
Nocturia[MeSHID:D053158]
Hemophilia A[MeSHID:D006467]
Polydipsia[MeSHID:D059606]
Pituitary Diseases[MeSHID:D010900]
Craniocerebral Trauma[MeSHID:D006259]
Central Diabetes Insipidus[MeSHID:D020790]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]		 3.35 approved unknown
click here to return to the previous page